Advances in laboratory testing for HIV

被引:14
作者
Dax, EM
Arnott, A
机构
[1] Natl Serol Reference Lab Australia, Fitzroy, Vic 3065, Australia
[2] Monash Univ, Dept Microbiol, Clayton, Vic 3168, Australia
关键词
HIV; diagnostic testing; screening; clinical management; quality assurance; advances; immunoassay; viral load;
D O I
10.1080/00313020400010922
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
In 2004, the diagnosis of established human immunodeficiency virus (HIV) infection can be made with close to 100% assurity. The extraordinarily engineered performances of HIV-screening assays are unprecedented. The well-established confirmatory tests performed by well-versed laboratories using criteria that are well understood in order to interpret the results of these tests give highly accurate outcomes of diagnostic testing strategies. Furthermore, the ability to monitor the progress of the infection and the viral pathogenesis is possible through the use of tests that quantify viral load or the peripheral CD4(+) T-cells and other lymphocyte sub-type levels. Newer laboratory testing mechanisms, such as assessment of reverse transcriptase activity and sophisticated cell staining and flow cytometric analyses, have been used to map disease processes and progress on a research level and may be used in future to fine-tune therapy and to follow disease progression in even greater detail. Regulation of all HIV tests is of the highest level in Australia. In-house tests will be expected to conform to the levels specified for commercially produced tests.
引用
收藏
页码:551 / 560
页数:10
相关论文
共 81 条
[11]  
Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P329
[12]   THE ABSENCE OR LOSS OF ANTIBODIES OF HIGH-AFFINITY TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) IS ASSOCIATED WITH DISEASE PROGRESSION IN HIV-1-INFECTED PATIENTS [J].
CHARGELEGUE, D ;
STANLEY, CM ;
OTOOLE, CM ;
COLVIN, BT ;
STEWARD, MW .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (03) :897-898
[13]   ISOLATION OF A NEW HUMAN RETROVIRUS FROM WEST-AFRICAN PATIENTS WITH AIDS [J].
CLAVEL, F ;
GUETARD, D ;
BRUNVEZINET, F ;
CHAMARET, S ;
REY, MA ;
SANTOSFERREIRA, MO ;
LAURENT, AG ;
DAUGUET, C ;
KATLAMA, C ;
ROUZIOUX, C ;
KLATZMANN, D ;
CHAMPALIMAUD, JL ;
MONTAGNIER, L .
SCIENCE, 1986, 233 (4761) :343-346
[14]   Using point-of-care testing to make rapid HIV-1 tests in labor really rapid [J].
Cohen, MH ;
Olszewski, Y ;
Branson, B ;
Robey, M ;
Love, F ;
Jamieson, DJ ;
Bulterys, M .
AIDS, 2003, 17 (14) :2121-2124
[15]   False positives for HIV using commercial viral load quantification assay [J].
de Mendoza, C ;
Holguín, A ;
Soriano, V .
AIDS, 1998, 12 (15) :2076-2077
[16]   First report of human immunodeficiency virus transmission via an RNA-screened blood donation [J].
Delwart, EL ;
Kalmin, ND ;
Jones, TS ;
Ladd, DJ ;
Foley, B ;
Tobler, LH ;
Tsui, RCP ;
Busch, MP .
VOX SANGUINIS, 2004, 86 (03) :171-177
[17]   A passive immunotherapy, PEHRG214, in patients infected with human immunodeficiency virus:: a phase I study [J].
Dezube, BJ ;
Proper, J ;
Zhang, JL ;
Choy, VJ ;
Weeden, W ;
Morrissey, J ;
Burns, EM ;
Dixon, JD ;
O'Loughlin, C ;
Williams, LA ;
Pickering, PJ ;
Crumpacker, CS ;
Gelder, FB .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (03) :500-503
[18]   Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population [J].
Dodd, RY ;
Notari, EP ;
Stramer, SL .
TRANSFUSION, 2002, 42 (08) :975-979
[19]   Recent experience with human immunodeficiency virus transmission by cellular blood products in Germany:: antibody screening is not sufficient to prevent transmission [J].
Dreier, J ;
Götting, C ;
Wolff, C ;
Petersen, N ;
Kleesiek, K .
VOX SANGUINIS, 2002, 82 (02) :80-83
[20]   Comparison of genotyping and phenotyping methods for determining susceptibility of HIV-1 to antiretroviral drugs [J].
Dunne, AL ;
Mitchell, FM ;
Coberly, SK ;
Hellmann, NS ;
Hoy, J ;
Mijch, A ;
Petropoulos, CJ ;
Mills, J ;
Crowe, SM .
AIDS, 2001, 15 (12) :1471-1475